Association between common variation in 120 candidate genes and breast cancer risk.
about
Genetic associations with sporadic neuroendocrine tumor riskComprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortiumIdentification of common variants in the SHBG gene affecting sex hormone-binding globulin levels and breast cancer risk in postmenopausal womenCommon genetic variation in candidate genes and susceptibility to subtypes of breast cancerChild development and molecular genetics: 14 years laterPathway analysis of GWAS provides new insights into genetic susceptibility to 3 inflammatory diseases.Comparison of population-based association study methods correcting for population stratificationBreast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial CohortAssociation between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancerGermline mutations and polymorphisms in the origins of cancers in women.Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breastMulti-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility.Variation in genes required for normal mitosis and risk of breast cancerDouble-bottom chaotic map particle swarm optimization based on chi-square test to determine gene-gene interactions.MicroRNA binding site polymorphisms as biomarkers in cancer management and research.Unique SNP in CD44 intron 1 and its role in breast cancer development.Association of the vascular endothelial growth factor -2578C/A polymorphism with cancer risk: A meta-analysis updateAn improved PSO algorithm for generating protective SNP barcodes in breast cancerAssociation of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysisAssociation between the Functional Polymorphism of Vascular Endothelial Growth Factor Gene and Breast Cancer: A Meta-Analysis.Association between the RAD51 135 G>C polymorphism and risk of cancer: a meta-analysis of 19,068 cases and 22,630 controls.In search of breast cancer culprits: suspecting the suspected and the unsuspectedUnravelling genes and pathways implicated in working memory of schizophrenia in Han ChinesePhosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumorsAssociation between the polymorphism rs3217927 of CCND2 and the risk of childhood acute lymphoblastic leukemia in a Chinese population.Combined effect of CYP1B1, COMT, GSTP1, and MnSOD genotypes and risk of postmenopausal breast cancer.The 'Pokemon' (ZBTB7) Gene: No Evidence of Association with Sporadic Breast Cancer.Association between RAD51 polymorphism and breast cancer susceptibility: a meta analysis.The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort.RAD51 135G>C substitution increases breast cancer risk in an ethnic-specific manner: a meta-analysis on 21,236 cases and 19,407 controls.A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effectsAdvances in breast cancer: pathways to personalized medicineMcs5c: a mammary carcinoma susceptibility locus located in a gene desert that associates with tenascin C expression.SNP discovery, expression and cis-regulatory variation in the UGT2B genes.Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British populationGenome-wide association study provides evidence for a breast cancer risk locus at 6q22.33.Genetic variation and its role in malignancyThe interleukin 10 -819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls.ESR1 single nucleotide polymorphisms predict breast cancer susceptibility in the central European Caucasian population.Polygenic susceptibility to breast cancer: current state-of-the-art.
P2860
Q23918559-A78E0510-4A2C-4049-87AC-9487FAEB174DQ24614574-1BA082E9-0F60-4709-B591-81B4213C8F2CQ24653491-7A4132B3-6207-4508-BB16-EBD20B1A2245Q24658131-4899D6F5-443A-4E4E-B5A5-FFE8EC16E689Q26853446-0A49CF65-BB19-4E18-8D08-38B5EFCE79AEQ30943588-DABF56A5-00A2-495C-99A5-876EA7248594Q33375723-7477828F-DF45-4351-8F7A-FCB2A137FE34Q33418922-8589CC8F-C33C-4897-B6AA-3E890526577FQ33471495-85F9422B-5D66-42ED-8459-10867FE44CD1Q33606675-F1FEE788-0D6E-408C-82F8-98C1A026DE5EQ33627202-12AFDF59-E114-48E9-B1A5-9163709753C4Q33628755-780E9E71-10DF-4B2B-8108-2D1B334050A6Q33636005-A2FD8DE7-E732-4C42-A47A-76A8DF41F724Q33661500-F5619054-5CBE-4F20-AD72-DE0A28A2B385Q34019040-8EAE8B6F-E5DE-44CF-9681-D59623A72EE1Q34069483-6909294E-18FB-4554-90BF-D826C876D5B1Q34265586-3C9D0860-17AE-4E9D-8559-AB844047A9EBQ34279774-581E0935-B263-483B-8FAF-E95A8AC3933AQ34435081-69800DC8-DCCC-499C-AC50-A86EA1A29F53Q34990498-4B06C6FF-4EF7-4EA1-9326-9674152B456CQ34990550-17818716-503C-4574-AF8C-53BE72693DFAQ35015572-094C8846-BE19-4D29-AAC9-1B7FBF235693Q35016729-A58BF580-A78F-46A1-BA05-39418A13804EQ35100928-6926BE03-C850-4612-B77A-FEF03AC11FBBQ35151947-DB2B7031-B1AF-47F8-8A7C-859E8267FDA1Q35154503-1106CA87-1095-4118-84CA-FFB212C18B56Q35180956-0C272F14-25D2-4C6C-97E4-A36D079A495BQ35480292-76F9322D-0106-41A8-8089-38BD401BAC81Q35558999-048C42F5-A6EE-4936-8CC5-4E468797D7AFQ35778027-72A84F3B-431D-4F76-9428-7CC8404D39B0Q35848518-113665E1-7C0D-45FA-9B40-FF742BD5997AQ35951346-FE4636B9-870A-44E3-8705-4036BACE0BEDQ36249015-6EBD8D6C-8753-4C38-BA38-A4010FAF9C61Q36276855-6D538F17-C0BE-462D-BFA4-3D4E18B5EC04Q36593602-6C5782FA-3B7A-4826-BC7F-E793857650C9Q36670312-25C7A473-9471-4E39-96EC-D94C4E4362ADQ36735686-60BAB585-3A85-4587-9451-26FD1AB033C9Q36737978-CBE09F6E-2936-4839-806E-5B41D8CA0C21Q36781658-6504ECC3-1E0A-4722-8DC4-28ACC18895A1Q37062641-3F5004FF-2D0C-4C5C-92E8-D2E92FBF7B0A
P2860
Association between common variation in 120 candidate genes and breast cancer risk.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Association between common variation in 120 candidate genes and breast cancer risk.
@ast
Association between common variation in 120 candidate genes and breast cancer risk.
@en
Association between common variation in 120 candidate genes and breast cancer risk.
@nl
type
label
Association between common variation in 120 candidate genes and breast cancer risk.
@ast
Association between common variation in 120 candidate genes and breast cancer risk.
@en
Association between common variation in 120 candidate genes and breast cancer risk.
@nl
prefLabel
Association between common variation in 120 candidate genes and breast cancer risk.
@ast
Association between common variation in 120 candidate genes and breast cancer risk.
@en
Association between common variation in 120 candidate genes and breast cancer risk.
@nl
P2093
P2860
P50
P1433
P1476
Association between common variation in 120 candidate genes and breast cancer risk.
@en
P2093
Bruce A J Ponder
Jonathan Tyrer
SEARCH Investigators
P2860
P356
10.1371/JOURNAL.PGEN.0030042
P577
2007-02-02T00:00:00Z